Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Natco Pharma Limited
NATCOPHARMNATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India. Address: Natco House, Hyderabad, India, 500034
Analytics
Objectif de Cours de WallStreet
113 397.63 INRRatio C/B
12.6742Rendement du dividende
0.4 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés NATCOPHARM
Analyse des dividendes NATCOPHARM
Croissance des dividendes sur 5 ans
12 %Croissance continue
2 annéesRatio de distribution Moyenne sur 5 ans
32 %Historique des dividendes NATCOPHARM
Valorisation des titres NATCOPHARM
financières NATCOPHARM
Résultats | 2019 | Dynamique |